Works matching AU Alleva, G.

Results: 14

Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice.

Published in:

2000

By:

Alleva, David G.;
Pavlovich, Ryan P.;
Grant, Christian;
Kaser, Steven B.;
Beller, David I.;
Alleva, D G;
Pavlovich, R P;
Grant, C;
Kaser, S B;
Beller, D I

Publication type:

journal article

Optimal two-stage spatial sampling design for estimating critical parameters of SARS-CoV-2 epidemic: Efficiency versus feasibility.

Published in:

Statistical Methods & Applications, 2023, v. 32, n. 3, p. 983, doi. 10.1007/s10260-023-00688-z

By:

Alleva, G.;
Arbia, G.;
Falorsi, P. D.;
Nardelli, V.;
Zuliani, A.

Publication type:

Article

Enhanced Palmitate-Induced Interleukin-8 Formation in Human Macrophages by Insulin or Prostaglandin E 2.

Published in:

Biomedicines, 2021, v. 9, n. 5, p. 449, doi. 10.3390/biomedicines9050449

By:

Henkel, Janin;
Klauder, Julia;
Statz, Meike;
Wohlenberg, Anne-Sophie;
Kuipers, Sonja;
Vahrenbrink, Madita;
Püschel, Gerhard Paul;
Alleva, David G.

Publication type:

Article

Induction of Antigen-Specific Tolerance in Autoimmune Diabetes with Nanoparticles Containing Hybrid Insulin Peptides.

Published in:

Biomedicines, 2021, v. 9, n. 3, p. 240, doi. 10.3390/biomedicines9030240

By:

DiLisio, James E.;
Haskins, Kathryn;
Alleva, David G.

Publication type:

Article

Non-Genetically Encoded Epitopes Are Relevant Targets in Autoimmune Diabetes.

Published in:

Biomedicines, 2021, v. 9, n. 2, p. 202, doi. 10.3390/biomedicines9020202

By:

Nguyen, Hai;
Guyer, Perrin;
Ettinger, Ruth A.;
James, Eddie A.;
Alleva, David G.

Publication type:

Article

Reversal of Hyperglycemia and Suppression of Type 1 Diabetes in the NOD Mouse with Apoptotic DNA Immunotherapy™ (ADi™), ADi-100.

Published in:

Biomedicines, 2020, v. 8, n. 3, p. 53, doi. 10.3390/biomedicines8030053

By:

Alleva, David G.;
Rezaee, Melika;
Yip, Linda;
Ren, Gang;
Rosenberg, Jarrett;
Concepcion, Waldo;
Escher, Alan;
Shabahang, Shahrokh;
Thakor, Avnesh S.

Publication type:

Article

Assessing Problematic States in Patients' Narratives: The Grid of Problematic States.

Published in:

Psychotherapy Research, 2003, v. 13, n. 3, p. 337, doi. 10.1093/ptr/kpg032

By:

A. Semerari;
A. Carcione;
G. Dimaggio;
M. Falcone;
G. Nicolò;
M. Procacci;
G. Alleva;
E. Mergenthaler

Publication type:

Article

Macrophage Priming and Activation During Fibrosarcoma Growth: Expression of c- myb, c- myc, c- fos, and c- fms.

Published in:

Immunological Investigations, 1994, v. 23, n. 6/7, p. 457, doi. 10.3109/08820139409066840

By:

Alleva, David G.;
Askew, David;
Burger, Carol J.;
Elgert, Klaus D.

Publication type:

Article

Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine.

Published in:

NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00830-2

By:

Alleva, David G.;
Feitsma, Eline A.;
Janssen, Yester F.;
Boersma, Hendrikus H.;
Lancaster, Thomas M.;
Sathiyaseelan, Thillainaygam;
Murikipudi, Sylaja;
Delpero, Andrea R.;
Scully, Melanie M.;
Ragupathy, Ramya;
Kotha, Sravya;
Haworth, Jeffrey R.;
Shah, Nishit J.;
Rao, Vidhya;
Nagre, Shashikant;
Ronca, Shannon E.;
Green, Freedom M.;
Shaw, Stephen A.;
Aminetzah, Ari;
Kruijff, Schelto

Publication type:

Article

An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1367514

By:

Alleva, David G.;
Delpero, Andrea R.;
Sathiyaseelan, Thillainaygam;
Murikipudi, Sylaja;
Lancaster, Thomas M.;
Atkinson, Mark A.;
Wasserfall, Clive H.;
Liping Yu;
Ragupathy, Ramya;
Bonami, Rachel H.;
Zion, Todd C.

Publication type:

Article

Tumour Growth Causes Suppression of Autoreactive T-Cell Proliferation by Disrupting Macrophage Responsiveness to Interferon-γ.

Published in:

Scandinavian Journal of Immunology, 1994, v. 39, n. 1, p. 31, doi. 10.1111/j.1365-3083.1994.tb03336.x

By:

Alleva, D. G.;
Burger, C. J.;
Elgert, K. D.

Publication type:

Article

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide.

Published in:

2002

By:

Alleva, David G.;
Gaur, Amitabh;
Jin, Liping;
Wegmann, Dale;
Gottlieb, Peter A.;
Pahuja, Anil;
Johnson, Eric B.;
Motheral, Theresa;
Putnam, Amy;
Crowe, Paul D.;
Ling, Nicholas;
Boehme, Stefen A.;
Conlon, Paul J.

Publication type:

journal article

Experimental Autoimmune Encephalomyelitis Develops in CC Chemokine Receptor 7-deficient Mice with Altered T-cell Responses.

Published in:

Scandinavian Journal of Immunology, 2006, v. 64, n. 4, p. 361, doi. 10.1111/j.1365-3083.2006.01787.x

By:

Pahuja, A.;
Maki, R. A.;
Hevezi, P. A.;
Chen, A.;
Verge, G. M.;
Lechner, S. M.;
Roth, R. B.;
Zlotnik, A.;
Alleva, D. G.

Publication type:

Article

Immunomodulation in Type 1 Diabetes by NBI-6024, an Altered Peptide Ligand of the Insulin B<sub>(9−23)</sub> Epitope.

Published in:

Scandinavian Journal of Immunology, 2006, v. 63, n. 1, p. 59, doi. 10.1111/j.1365-3083.2005.01705.x

By:

Alleva, D. G.;
Maki, R. A.;
Putnam, A. L.;
Robinson, J. M.;
Kipnes, M. S.;
Dandona, P.;
Marks, J. B.;
Simmons, D. L.;
Greenbaum, C. J.;
Jimenez, R. G.;
Conlon, P. J.;
Gottlieb, P. A.

Publication type:

Article